Form 8-K - Current report:
SEC Accession No. 0001144204-16-141648
Filing Date
2016-12-29
Accepted
2016-12-29 08:01:40
Documents
8
Period of Report
2016-12-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v455882_8k.htm 8-K 37907
2 EXHIBIT 10.1 v455882_ex10-1.htm EX-10.1 25071
3 EXHIBIT 10.2 v455882_ex10-2.htm EX-10.2 30783
4 EXHIBIT 10.3 v455882_ex10-3.htm EX-10.3 26960
5 EXHIBIT 10.4 v455882_ex10-4.htm EX-10.4 26100
6 EXHIBIT 10.5 v455882_ex10-5.htm EX-10.5 24954
7 EXHIBIT 10.6 v455882_ex10-6.htm EX-10.6 26933
8 EXHIBIT 10.7 v455882_ex10-7.htm EX-10.7 29751
  Complete submission text file 0001144204-16-141648.txt   229800
Mailing Address 1450 INFINITE DRIVE LOUISVILLE CO 80027
Business Address 1450 INFINITE DRIVE LOUISVILLE CO 80027 650-847-1919
AntriaBio, Inc. (Filer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-54495 | Film No.: 162073521
SIC: 2834 Pharmaceutical Preparations